119 related articles for article (PubMed ID: 3351846)
1. Potential antitumor agents. 54. Chromophore requirements for in vivo antitumor activity among the general class of linear tricyclic carboxamides.
Palmer BD; Rewcastle GW; Atwell GJ; Baguley BC; Denny WA
J Med Chem; 1988 Apr; 31(4):707-12. PubMed ID: 3351846
[TBL] [Abstract][Full Text] [Related]
2. Potential antitumor agents. 64. Synthesis and antitumor evaluation of dibenzo[1,4]dioxin-1-carboxamides: a new class of weakly binding DNA-intercalating agents.
Lee HH; Palmer BD; Boyd M; Baguley BC; Denny WA
J Med Chem; 1992 Jan; 35(2):258-66. PubMed ID: 1310119
[TBL] [Abstract][Full Text] [Related]
3. Potential antitumor agents. 55. 6-Phenylphenanthridine-4-carboxamides: a new class of DNA-intercalating antitumor agents.
Atwell GJ; Baguley BC; Denny WA
J Med Chem; 1988 Apr; 31(4):774-9. PubMed ID: 3351855
[TBL] [Abstract][Full Text] [Related]
4. Potential antitumor agents. 50. In vivo solid-tumor activity of derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.
Atwell GJ; Rewcastle GW; Baguley BC; Denny WA
J Med Chem; 1987 Apr; 30(4):664-9. PubMed ID: 3560161
[TBL] [Abstract][Full Text] [Related]
5. Potential antitumor agents. 59. Structure-activity relationships for 2-phenylbenzimidazole-4-carboxamides, a new class of "minimal" DNA-intercalating agents which may not act via topoisomerase II.
Denny WA; Rewcastle GW; Baguley BC
J Med Chem; 1990 Feb; 33(2):814-9. PubMed ID: 2153829
[TBL] [Abstract][Full Text] [Related]
6. Potential antitumor agents. 57. 2-Phenylquinoline-8-carboxamides as "minimal" DNA-intercalating antitumor agents with in vivo solid tumor activity.
Atwell GJ; Baguley BC; Denny WA
J Med Chem; 1989 Feb; 32(2):396-401. PubMed ID: 2913299
[TBL] [Abstract][Full Text] [Related]
7. Potential antitumor agents. 56. "Minimal" DNA-intercalating ligands as antitumor drugs: phenylquinoline-8-carboxamides.
Atwell GJ; Bos CD; Baguley BC; Denny WA
J Med Chem; 1988 May; 31(5):1048-52. PubMed ID: 3361574
[TBL] [Abstract][Full Text] [Related]
8. Potential antitumor agents. 53. Synthesis, DNA binding properties, and biological activity of perimidines designed as "minimal" DNA-intercalating agents.
Herbert JM; Woodgate PD; Denny WA
J Med Chem; 1987 Nov; 30(11):2081-6. PubMed ID: 3669016
[TBL] [Abstract][Full Text] [Related]
9. Potential antitumor agents. 49. 5-substituted derivatives of N-[2-(dimethylamino)ethyl]-9-aminoacridine-4-carboxamide with in vivo solid-tumor activity.
Denny WA; Atwell GJ; Rewcastle GW; Baguley BC
J Med Chem; 1987 Apr; 30(4):658-63. PubMed ID: 3560160
[TBL] [Abstract][Full Text] [Related]
10. Kinetic studies of the binding of acridinecarboxamide topoisomerase poisons to DNA: implications for mode of binding of ligands with uncharged chromophores.
Wakelin LP; Adams A; Denny WA
J Med Chem; 2002 Feb; 45(4):894-901. PubMed ID: 11831901
[TBL] [Abstract][Full Text] [Related]
11. Dimeric analogues of non-cationic tricyclic aromatic carboxamides are a new class of cytotoxic agents.
Spicer JA; Gamage SA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
Anticancer Drug Des; 1999 Jun; 14(3):281-9. PubMed ID: 10500503
[TBL] [Abstract][Full Text] [Related]
12. Relationships between DNA-binding kinetics and biological activity for the 9-aminoacridine-4-carboxamide class of antitumor agents.
Wakelin LP; Atwell GJ; Rewcastle GW; Denny WA
J Med Chem; 1987 May; 30(5):855-61. PubMed ID: 3572974
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, DNA intercalation and 3D QSAR analysis of cis-2,4,5-trisubstituted-1,3-dithiolanes as a novel class of antitumor agents.
Huang F; Zhao M; Zhang X; Wang C; Qian K; Kuo RY; Morris-Natschke S; Lee KH; Peng S
Bioorg Med Chem; 2009 Aug; 17(16):6085-95. PubMed ID: 19631550
[TBL] [Abstract][Full Text] [Related]
14. Comparative biodistribution and metabolism of carbon-11-labeled N-[2-(dimethylamino)ethyl]acridine-4-carboxamide and DNA-intercalating analogues.
Osman S; Rowlinson-Busza G; Luthra SK; Aboagye EO; Brown GD; Brady F; Myers R; Gamage SA; Denny WA; Baguley BC; Price PM
Cancer Res; 2001 Apr; 61(7):2935-44. PubMed ID: 11306471
[TBL] [Abstract][Full Text] [Related]
15. Acridinecarboxamide topoisomerase poisons: structural and kinetic studies of the DNA complexes of 5-substituted 9-amino-(N-(2-dimethylamino)ethyl)acridine-4-carboxamides.
Adams A; Guss JM; Collyer CA; Denny WA; Prakash AS; Wakelin LP
Mol Pharmacol; 2000 Sep; 58(3):649-58. PubMed ID: 10953060
[TBL] [Abstract][Full Text] [Related]
16. Electron-deficient DNA-intercalating agents as antitumor drugs: aza analogues of the experimental clinical agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.
Chen Q; Deady LW; Baguley BC; Denny WA
J Med Chem; 1994 Mar; 37(5):593-7. PubMed ID: 8126699
[TBL] [Abstract][Full Text] [Related]
17. Molecular modeling study of intercalation complexes of tricyclic carboxamides with d(CCGGCGCCGG)₂ and d(CGCGAATTCGCG)₂.
Varvaresou A; Iakovou K
J Mol Model; 2011 Aug; 17(8):2041-50. PubMed ID: 21153908
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, DNA binding, and biological activity of a series of DNA minor-groove-binding intercalating drugs.
Bailly C; Pommery N; Houssin R; Henichart JP
J Pharm Sci; 1989 Nov; 78(11):910-7. PubMed ID: 2621573
[TBL] [Abstract][Full Text] [Related]
19. Polysubstituted pyrazoles, part 6. Synthesis of some 1-(4-chlorophenyl)-4-hydroxy-1H-pyrazol-3-carbonyl derivatives linked to nitrogenous heterocyclic ring systems as potential antitumor agents.
Rostom SA
Bioorg Med Chem; 2010 Apr; 18(7):2767-76. PubMed ID: 20207545
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents.
Antonini I; Polucci P; Magnano A; Gatto B; Palumbo M; Menta E; Pescalli N; Martelli S
J Med Chem; 2003 Jul; 46(14):3109-15. PubMed ID: 12825949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
